UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma

Journal for immunotherapy of cancer, 2021-06, Vol.9 (6), p.e002057

2021

Volltextzugriff (PDF)

Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study

The Lancet infectious diseases, 2017-08, Vol.17 (8), p.854-866

2017

Volltextzugriff (PDF)

IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophan

Oncoimmunology, 2012-12, Vol.1 (9), p.1460-1468

2012

Volltextzugriff (PDF)

Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors

Journal for immunotherapy of cancer, 2018-06, Vol.6 (1), p.61-12, Article 61

2018

Volltextzugriff (PDF)

Emergency postexposure vaccination with vesicular stomatitis virus-vectored Ebola vaccine after needlestick

JAMA : the journal of the American Medical Association, 2015-03, Vol.313 (12), p.1249

2015

Volltextzugriff (PDF)

Addition of αGal HyperAcute™ technology to recombinant avian influenza vaccines induces strong low-dose antibody responses

PloS one, 2017-08, Vol.12 (8), p.e0182683-e0182683

2017

Volltextzugriff (PDF)

A replication-incompetent Rift Valley fever vaccine: Chimeric virus-like particles protect mice and rats against lethal challenge

Virology (New York, N.Y.), 2010-02, Vol.397 (1), p.187-198

2010

Volltextzugriff (PDF)

Immunity to the α(1,3)galactosyl epitope provides protection in mice challenged with colon cancer cells expressing α(1,3)galactosyl-transferase: A novel suicide gene for cancer gene therapy

Cancer research (Chicago, Ill.), 2003-03, Vol.63 (5), p.987-993

2003

Volltextzugriff (PDF)

U6 promoter-enhanced GlnUAG suppressor tRNA has higher suppression efficacy and can be stably expressed in 293 cells

The journal of gene medicine, 2013-02, Vol.15 (2), p.93-101

2013

Volltextzugriff (PDF)

Antitumor effects on human melanoma xenografts of an amplicon vector transducing the herpes thymidine kinase gene followed by ganciclovir

Cancer gene therapy, 2002-01, Vol.9 (1), p.1-8

2002

Volltextzugriff (PDF)

Radioisotope concentrator gene therapy using the sodium/iodide symporter gene

Cancer research (Chicago, Ill.), 1999-02, Vol.59 (3), p.661-668

1999

Volltextzugriff (PDF)

Cellular immunotherapy study of prostate cancer patients and resulting IgG responses to peptide epitopes predicted from prostate tumor-associated autoantigens

Journal of immunotherapy (1997), 2013-01, Vol.36 (1), p.57-65

2013

Volltextzugriff (PDF)

Effective treatment of preexisting melanoma with whole cell vaccines expressing α(1,3)-galactosyl epitopes

Cancer research (Chicago, Ill.), 2005-11, Vol.65 (22), p.10555-10561

2005

Volltextzugriff (PDF)

Pulmonary Radiation Injury

Chest, 1997-04, Vol.111 (4), p.1061-1076

1997

Volltextzugriff (PDF)

Novel suspension cell-based vaccine production systems for Rift Valley fever virus-like particles

Journal of virological methods, 2010-11, Vol.169 (2), p.259-268

2010

Volltextzugriff (PDF)

Combination immunotherapy for high-risk resected and metastatic melanoma patients

The Ochsner journal, 2014, Vol.14 (2), p.164-174

2014

Volltextzugriff (PDF)

Co-expression of alpha(1,3)galactosyltransferase and Bacillus thuringiensis PIPLC enhances hyperacute rejection of tumor cells

Cancer Immunology, Immunotherapy, 2007-01, Vol.56 (1), p.25-34

2007

Volltextzugriff (PDF)

Complete protection against melanoma in absence of autoimmune depigmentation after rejection of melanoma cells expressing α(1,3)galactosyl epitopes

Cancer Immunology, Immunotherapy, 2005-10, Vol.54 (10), p.999-1009

2005

Volltextzugriff (PDF)

Direct Observation of GFP Gene Expression Transduced with HSV-1/EBV Amplicon Vector in Unfixed Tumor Tissue

BioTechniques, 2000-02, Vol.28 (2), p.206-208

2000

Volltextzugriff (PDF)

Efficacy of alpha-1,3-galactosyltransferase-expressing allogeneic renal cell carcinoma immunotherapy in patients (pts) with refractory metastatic renal cell carcinoma (mRCC)

Journal of clinical oncology, 2019-03, Vol.37 (7_suppl), p.590-590

2019

Volltextzugriff (PDF)

Iron chelators increase the resistance of Ataxia telangeictasia cells to oxidative stress

DNA repair, 2004-10, Vol.3 (10), p.1263-1272

2004

Volltextzugriff (PDF)

Abstract 6540: Regression of metastatic cancer and abscopal effects following in situ vaccination by cryosurgical tumor cell lysis and intratumoral immunotherapy: A case series

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.6540-6540

2020

Volltextzugriff (PDF)

A phase 1 study of alpha-1,3-galactosyltransferase-expressing allogeneic renal cell carcinoma immunotherapy in patients with metastatic renal cell cancer

Journal of clinical oncology, 2017-02, Vol.35 (6_suppl), p.528-528

2017

Volltextzugriff (PDF)

High‐throughput fluorescent screening of transgenic animals: Phenotyping and haplotyping

Cytometry. Part A, 2006-10, Vol.69A (10), p.1092-1095

2006

Volltextzugriff (PDF)

1 – 25 von 358

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(289)
Mit Volltextzugriff
(303)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(353)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(28)
Cancer Research
(17)
Osteoarthritis And Cartilage
(14)
Circulation
(8)
Journal Of Magnetic Resonance Imaging
(8)
Human Gene Therapy
(6)
College English
(5)
Journal Of Neurosurgery
(5)
Nature
(5)
Plos One
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma

Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study

IDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophan

Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors

Emergency postexposure vaccination with vesicular stomatitis virus-vectored Ebola vaccine after needlestick

Addition of αGal HyperAcute™ technology to recombinant avian influenza vaccines induces strong low-dose antibody responses

A replication-incompetent Rift Valley fever vaccine: Chimeric virus-like particles protect mice and rats against lethal challenge

Immunity to the α(1,3)galactosyl epitope provides protection in mice challenged with colon cancer cells expressing α(1,3)galactosyl-transferase: A novel suicide gene for cancer gene therapy

U6 promoter-enhanced GlnUAG suppressor tRNA has higher suppression efficacy and can be stably expressed in 293 cells

Antitumor effects on human melanoma xenografts of an amplicon vector transducing the herpes thymidine kinase gene followed by ganciclovir

Radioisotope concentrator gene therapy using the sodium/iodide symporter gene

Cellular immunotherapy study of prostate cancer patients and resulting IgG responses to peptide epitopes predicted from prostate tumor-associated autoantigens

Effective treatment of preexisting melanoma with whole cell vaccines expressing α(1,3)-galactosyl epitopes

Pulmonary Radiation Injury

Novel suspension cell-based vaccine production systems for Rift Valley fever virus-like particles

A Recombinant Vesicular Stomatitis Virus Ebola Vaccine

Combination immunotherapy for high-risk resected and metastatic melanoma patients

Co-expression of alpha(1,3)galactosyltransferase and Bacillus thuringiensis PIPLC enhances hyperacute rejection of tumor cells

Complete protection against melanoma in absence of autoimmune depigmentation after rejection of melanoma cells expressing α(1,3)galactosyl epitopes

Direct Observation of GFP Gene Expression Transduced with HSV-1/EBV Amplicon Vector in Unfixed Tumor Tissue

Efficacy of alpha-1,3-galactosyltransferase-expressing allogeneic renal cell carcinoma immunotherapy in patients (pts) with refractory metastatic renal cell carcinoma (mRCC)

Iron chelators increase the resistance of Ataxia telangeictasia cells to oxidative stress

Abstract 6540: Regression of metastatic cancer and abscopal effects following in situ vaccination by cryosurgical tumor cell lysis and intratumoral immunotherapy: A case series

A phase 1 study of alpha-1,3-galactosyltransferase-expressing allogeneic renal cell carcinoma immunotherapy in patients with metastatic renal cell cancer

High‐throughput fluorescent screening of transgenic animals: Phenotyping and haplotyping

Suchergebnisse filtern